WWS Calendar

Menacing Mosquitos, Biting Bats, and Tormenting Ticks: Health Protection Priorities

Feb 29, 2016 04:30PM to 06:00PM
Open to the Public
Julie Gerberding, M.D., MPH, Executive Vice President for Strategic Communications, Global Public Policy and Population Health, Merck; former head of the Centers for Disease Control and Prevention (CDC)

Dr. Julie L. Gerberding, executive vice president for strategic communications, global public policy and population health at Merck & Co. and former head of the Centers for Disease Control and Prevention (CDC), will present a public talk titled, "Menacing Mosquitos, Biting Bats, and Tormenting Ticks:  Health Protection Priorities," at 4:30 p.m., Monday, Feb. 29, 2016, Robertson Hall, Princeton University.

Gerberding is this year’s Gilbert S. Omenn '61 Lecturer in Science Policy at the School.

Gerberding, who also has responsibility for the Merck for Mothers program and the Merck Foundation, is building new initiatives designed to accelerate Merck’s ability to contribute to improved population health – a measure increasingly valued by consumers, health organizations and communities. 

Gerberding joined Merck in January 2010 as president of Merck Vaccines. She led a successful global expansion of the vaccine business and improved the availability and affordability of vaccines in emerging markets and some of the most resource-limited countries in the world.

From 2002 to 2009, Gerberding served as director of the CDC. In this position, she led the agency through more than 40 emergency responses to public health crises, including anthrax bioterrorism, SARS and natural disasters. She also advised governments around the world on such urgent health issues as pandemic preparedness, AIDS, antimicrobial resistance, tobacco and cancer.

Prior to joining the CDC, Gerberding was a tenured faculty member at the University of California, San Francisco and directed the Prevention Epicenter, a multidisciplinary research, training, and clinical service program focused on the prevention of infections in patients and their healthcare providers. 

Gerberding received her undergraduate and medical degrees from Case Western Reserve University. She completed her internship and residency in internal medicine and a fellowship in clinical pharmacology and infectious diseases at the University of California and received a Masters in Public Health at the University of California, Berkeley. 

She was named to Forbes Magazine's “100 Most Powerful Women in the World” in 2005 through 2008 and TIME Magazine's “100 Most Influential People in the World” in 2004.